SUSMED Co., Ltd. announced a private placement of non convertible preferred shares on May 11, 2020. The investment ratio is expected to be about 2.5-3.0% of the total number of issued shares. The transaction will include participation from new investor Suzuken Co., Ltd. (TSE:9987).